athenahealth Names Suki Preferred Partner for Ambient AI Documentation
The designation makes Suki athenahealth's recommended ambient intelligence vendor for a network the EHR company puts at 170,000 providers, and gives Suki fast-track access to new athenaOne features.
Key points
- Suki said on January 26 that athenahealth selected it as a Preferred Solution Partner in the ambient intelligence category, a designation that denotes athenahealth's formal recommendation.
- Suki says 450-plus practices and 3,400 monthly active users use its technology through Suki for Clinicians and athenahealth's Ambient Notes, generating about 500,000 clinical notes a month.
- The adoption and growth figures are company-reported; the release does not disclose financial terms.
Suki, a Redwood City, California, developer of AI documentation software for clinicians, said on January 26 that athenahealth has selected it as a Preferred Solution Partner for ambient intelligence, a designation the electronic health record company describes as its formal recommendation for a validated, trusted solution in that category, according to Suki's announcement.
The release was distributed by Business Wire on January 26, 2026 and was read via Wedbush, which republished it; the copy on Suki's own site carries a 2025 dateline. The companies did not disclose financial terms.
How the software reaches athenaOne users
Suki describes its product as an ambient clinical intelligence layer embedded at the point of care that powers documentation, revenue cycle management and clinical reasoning. athenahealth, which the release calls a provider of network-enabled software and services for health care practices and systems, sells the athenaOne platform. Suki's technology is available to athenaOne customers in two ways: through Suki's own app, Suki for Clinicians, in the athenahealth Marketplace, and inside athenahealth's Ambient Notes offering, which embeds Suki's technology through Suki for Partners, a developer toolkit with an SDK and APIs that other health technology companies can use to build Suki's capabilities into their own products, the company said.
Suki said its integration places the tool directly within clinicians' daily workflows in athenaOne, with the aim of reducing the administrative burden that it said drives burnout.
The designation signals athenahealth's recommendation in the ambient AI category to its network of 170,000 providers and gives Suki fast-track access to integrate new athenaOne features, according to the release.
“This partnership not only accelerates innovation but removes workflow friction and ensures that ambient intelligence can reach every corner of the athenahealth network,” said Punit Soni, Suki's chief executive and founder.
“Artificial intelligence has the potential to transform clinical practice, but it needs to be deeply embedded, easy to use, and designed for scale,” Soni said.
Michael Palantoni, athenahealth's chief strategy and corporate development officer, said adding Suki to the program lets athenahealth “offer our customers industry leading ambient clinical intelligence experiences that seamlessly interface with athenaOne workflows.”
Company-reported adoption
Suki said 450-plus practices and 3,400 monthly active users use its technology across Suki for Clinicians and Ambient Notes combined, a 50% increase over the previous six months, and that it generates about 500,000 clinical notes a month for athenaOne providers. The company also said Suki for Clinicians has an adoption rate above 82%, which it called the highest in the industry; it did not say how that rate is measured.
Suki also claims that, on average, its software drives an 81% increase in practice satisfaction and $1,688 in incremental monthly revenue per user; the release does not say how those figures were calculated. The company is backed by Venrock, First Round, Flare Capital Partners, March Capital and Hedosophia, according to the release.